nodes	percent_of_prediction	percent_of_DWPC	metapath
Bretylium—ATP1A1—oviduct—uterine cancer	0.0782	0.205	CbGeAlD
Bretylium—ATP1A1—exocrine gland—uterine cancer	0.0451	0.119	CbGeAlD
Bretylium—ATP1A1—myometrium—uterine cancer	0.025	0.0657	CbGeAlD
Bretylium—Paranoia—Medroxyprogesterone Acetate—uterine cancer	0.0242	0.0391	CcSEcCtD
Bretylium—Tenderness—Progesterone—uterine cancer	0.0209	0.0337	CcSEcCtD
Bretylium—ATP1A1—epithelium—uterine cancer	0.0196	0.0516	CbGeAlD
Bretylium—ATP1A1—uterine cervix—uterine cancer	0.0195	0.0512	CbGeAlD
Bretylium—ATP1A1—smooth muscle tissue—uterine cancer	0.0189	0.0497	CbGeAlD
Bretylium—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.0189	0.0305	CcSEcCtD
Bretylium—ATP1A1—decidua—uterine cancer	0.0185	0.0487	CbGeAlD
Bretylium—ATP1A1—renal system—uterine cancer	0.0182	0.0479	CbGeAlD
Bretylium—ATP1A1—endometrium—uterine cancer	0.0176	0.0463	CbGeAlD
Bretylium—ATP1A1—mammalian vulva—uterine cancer	0.017	0.0448	CbGeAlD
Bretylium—SLC6A2—decidua—uterine cancer	0.0165	0.0433	CbGeAlD
Bretylium—Lightheadedness—Progesterone—uterine cancer	0.0163	0.0263	CcSEcCtD
Bretylium—ATP1A1—uterus—uterine cancer	0.0162	0.0426	CbGeAlD
Bretylium—ATP1A1—female reproductive system—uterine cancer	0.0146	0.0383	CbGeAlD
Bretylium—Nasal congestion—Progesterone—uterine cancer	0.0145	0.0234	CcSEcCtD
Bretylium—ATP1A1—female gonad—uterine cancer	0.0133	0.0349	CbGeAlD
Bretylium—ATP1A1—vagina—uterine cancer	0.0132	0.0347	CbGeAlD
Bretylium—Affect lability—Progesterone—uterine cancer	0.013	0.021	CcSEcCtD
Bretylium—SLC6A2—female reproductive system—uterine cancer	0.013	0.0341	CbGeAlD
Bretylium—Mood swings—Progesterone—uterine cancer	0.0125	0.0202	CcSEcCtD
Bretylium—Affect lability—Medroxyprogesterone Acetate—uterine cancer	0.0118	0.019	CcSEcCtD
Bretylium—Psychotic disorder—Medroxyprogesterone Acetate—uterine cancer	0.0117	0.0189	CcSEcCtD
Bretylium—Mood swings—Medroxyprogesterone Acetate—uterine cancer	0.0113	0.0183	CcSEcCtD
Bretylium—Sweating increased—Progesterone—uterine cancer	0.0111	0.018	CcSEcCtD
Bretylium—Angina pectoris—Progesterone—uterine cancer	0.0111	0.018	CcSEcCtD
Bretylium—Orthostatic hypotension—Medroxyprogesterone Acetate—uterine cancer	0.0109	0.0177	CcSEcCtD
Bretylium—Sweating increased—Medroxyprogesterone Acetate—uterine cancer	0.0101	0.0163	CcSEcCtD
Bretylium—Conjunctivitis—Progesterone—uterine cancer	0.0099	0.016	CcSEcCtD
Bretylium—Body temperature increased—Carboplatin—uterine cancer	0.00977	0.0158	CcSEcCtD
Bretylium—Lethargy—Dactinomycin—uterine cancer	0.00953	0.0154	CcSEcCtD
Bretylium—ATP1A1—lymph node—uterine cancer	0.00853	0.0224	CbGeAlD
Bretylium—Bradycardia—Medroxyprogesterone Acetate—uterine cancer	0.00843	0.0136	CcSEcCtD
Bretylium—SLC6A2—lymph node—uterine cancer	0.00758	0.0199	CbGeAlD
Bretylium—Vertigo—Progesterone—uterine cancer	0.00715	0.0115	CcSEcCtD
Bretylium—Syncope—Progesterone—uterine cancer	0.00714	0.0115	CcSEcCtD
Bretylium—Loss of consciousness—Progesterone—uterine cancer	0.007	0.0113	CcSEcCtD
Bretylium—Hypertension—Progesterone—uterine cancer	0.00687	0.0111	CcSEcCtD
Bretylium—Anxiety—Progesterone—uterine cancer	0.00675	0.0109	CcSEcCtD
Bretylium—Confusional state—Progesterone—uterine cancer	0.00655	0.0106	CcSEcCtD
Bretylium—Vertigo—Medroxyprogesterone Acetate—uterine cancer	0.00648	0.0105	CcSEcCtD
Bretylium—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.00647	0.0104	CcSEcCtD
Bretylium—Shock—Progesterone—uterine cancer	0.00639	0.0103	CcSEcCtD
Bretylium—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.00634	0.0102	CcSEcCtD
Bretylium—Hyperhidrosis—Progesterone—uterine cancer	0.00628	0.0101	CcSEcCtD
Bretylium—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.00612	0.00987	CcSEcCtD
Bretylium—Flushing—Dactinomycin—uterine cancer	0.006	0.00968	CcSEcCtD
Bretylium—Confusional state—Medroxyprogesterone Acetate—uterine cancer	0.00593	0.00958	CcSEcCtD
Bretylium—Dyspnoea—Progesterone—uterine cancer	0.00579	0.00935	CcSEcCtD
Bretylium—Shock—Medroxyprogesterone Acetate—uterine cancer	0.00579	0.00935	CcSEcCtD
Bretylium—Ventricular extrasystoles—Epirubicin—uterine cancer	0.00578	0.00933	CcSEcCtD
Bretylium—Sweating increased—Etoposide—uterine cancer	0.00569	0.00919	CcSEcCtD
Bretylium—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.00569	0.00918	CcSEcCtD
Bretylium—Feeling abnormal—Progesterone—uterine cancer	0.00535	0.00864	CcSEcCtD
Bretylium—Ventricular extrasystoles—Doxorubicin—uterine cancer	0.00535	0.00863	CcSEcCtD
Bretylium—Gastrointestinal pain—Progesterone—uterine cancer	0.00531	0.00857	CcSEcCtD
Bretylium—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.00525	0.00847	CcSEcCtD
Bretylium—Hiccups—Epirubicin—uterine cancer	0.00522	0.00843	CcSEcCtD
Bretylium—Body temperature increased—Progesterone—uterine cancer	0.00513	0.00829	CcSEcCtD
Bretylium—Abdominal pain—Progesterone—uterine cancer	0.00513	0.00829	CcSEcCtD
Bretylium—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.00485	0.00783	CcSEcCtD
Bretylium—Hiccups—Doxorubicin—uterine cancer	0.00483	0.0078	CcSEcCtD
Bretylium—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.00481	0.00777	CcSEcCtD
Bretylium—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00465	0.00751	CcSEcCtD
Bretylium—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.00465	0.00751	CcSEcCtD
Bretylium—Diarrhoea—Progesterone—uterine cancer	0.00444	0.00717	CcSEcCtD
Bretylium—Flushing—Etoposide—uterine cancer	0.00434	0.007	CcSEcCtD
Bretylium—Dizziness—Progesterone—uterine cancer	0.0043	0.00693	CcSEcCtD
Bretylium—Vomiting—Progesterone—uterine cancer	0.00413	0.00666	CcSEcCtD
Bretylium—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00403	0.0065	CcSEcCtD
Bretylium—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.00389	0.00628	CcSEcCtD
Bretylium—Lethargy—Epirubicin—uterine cancer	0.00387	0.00624	CcSEcCtD
Bretylium—Nausea—Progesterone—uterine cancer	0.00386	0.00623	CcSEcCtD
Bretylium—Feeling abnormal—Dactinomycin—uterine cancer	0.00378	0.00611	CcSEcCtD
Bretylium—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00375	0.00606	CcSEcCtD
Bretylium—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00374	0.00604	CcSEcCtD
Bretylium—Affect lability—Epirubicin—uterine cancer	0.00373	0.00602	CcSEcCtD
Bretylium—Vertigo—Etoposide—uterine cancer	0.00366	0.0059	CcSEcCtD
Bretylium—Body temperature increased—Dactinomycin—uterine cancer	0.00363	0.00586	CcSEcCtD
Bretylium—Abdominal pain—Dactinomycin—uterine cancer	0.00363	0.00586	CcSEcCtD
Bretylium—Mood swings—Epirubicin—uterine cancer	0.00359	0.00579	CcSEcCtD
Bretylium—Loss of consciousness—Etoposide—uterine cancer	0.00358	0.00577	CcSEcCtD
Bretylium—Lethargy—Doxorubicin—uterine cancer	0.00358	0.00577	CcSEcCtD
Bretylium—Hypertension—Etoposide—uterine cancer	0.00351	0.00567	CcSEcCtD
Bretylium—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.0035	0.00564	CcSEcCtD
Bretylium—Orthostatic hypotension—Epirubicin—uterine cancer	0.00346	0.00559	CcSEcCtD
Bretylium—Affect lability—Doxorubicin—uterine cancer	0.00345	0.00557	CcSEcCtD
Bretylium—Confusional state—Etoposide—uterine cancer	0.00335	0.00541	CcSEcCtD
Bretylium—Mood swings—Doxorubicin—uterine cancer	0.00332	0.00536	CcSEcCtD
Bretylium—Hyperhidrosis—Etoposide—uterine cancer	0.00321	0.00518	CcSEcCtD
Bretylium—Orthostatic hypotension—Doxorubicin—uterine cancer	0.0032	0.00517	CcSEcCtD
Bretylium—Angina pectoris—Epirubicin—uterine cancer	0.00319	0.00515	CcSEcCtD
Bretylium—Diarrhoea—Dactinomycin—uterine cancer	0.00314	0.00507	CcSEcCtD
Bretylium—Dyspnoea—Etoposide—uterine cancer	0.00296	0.00478	CcSEcCtD
Bretylium—Angina pectoris—Doxorubicin—uterine cancer	0.00295	0.00476	CcSEcCtD
Bretylium—Vomiting—Dactinomycin—uterine cancer	0.00292	0.00471	CcSEcCtD
Bretylium—Conjunctivitis—Epirubicin—uterine cancer	0.00284	0.00458	CcSEcCtD
Bretylium—Feeling abnormal—Etoposide—uterine cancer	0.00274	0.00442	CcSEcCtD
Bretylium—Nausea—Dactinomycin—uterine cancer	0.00273	0.0044	CcSEcCtD
Bretylium—Gastrointestinal pain—Etoposide—uterine cancer	0.00272	0.00438	CcSEcCtD
Bretylium—Bradycardia—Epirubicin—uterine cancer	0.00267	0.00431	CcSEcCtD
Bretylium—Abdominal pain—Etoposide—uterine cancer	0.00263	0.00424	CcSEcCtD
Bretylium—Body temperature increased—Etoposide—uterine cancer	0.00263	0.00424	CcSEcCtD
Bretylium—Conjunctivitis—Doxorubicin—uterine cancer	0.00263	0.00424	CcSEcCtD
Bretylium—Bradycardia—Doxorubicin—uterine cancer	0.00247	0.00399	CcSEcCtD
Bretylium—Flushing—Epirubicin—uterine cancer	0.00243	0.00393	CcSEcCtD
Bretylium—Diarrhoea—Etoposide—uterine cancer	0.00227	0.00367	CcSEcCtD
Bretylium—Flushing—Doxorubicin—uterine cancer	0.00225	0.00363	CcSEcCtD
Bretylium—Dizziness—Etoposide—uterine cancer	0.0022	0.00355	CcSEcCtD
Bretylium—Vomiting—Etoposide—uterine cancer	0.00211	0.00341	CcSEcCtD
Bretylium—Vertigo—Epirubicin—uterine cancer	0.00205	0.00331	CcSEcCtD
Bretylium—Syncope—Epirubicin—uterine cancer	0.00205	0.0033	CcSEcCtD
Bretylium—Loss of consciousness—Epirubicin—uterine cancer	0.00201	0.00324	CcSEcCtD
Bretylium—Nausea—Etoposide—uterine cancer	0.00197	0.00319	CcSEcCtD
Bretylium—Hypertension—Epirubicin—uterine cancer	0.00197	0.00318	CcSEcCtD
Bretylium—Anxiety—Epirubicin—uterine cancer	0.00194	0.00312	CcSEcCtD
Bretylium—Vertigo—Doxorubicin—uterine cancer	0.0019	0.00306	CcSEcCtD
Bretylium—Syncope—Doxorubicin—uterine cancer	0.00189	0.00306	CcSEcCtD
Bretylium—Confusional state—Epirubicin—uterine cancer	0.00188	0.00303	CcSEcCtD
Bretylium—Loss of consciousness—Doxorubicin—uterine cancer	0.00186	0.003	CcSEcCtD
Bretylium—Shock—Epirubicin—uterine cancer	0.00183	0.00296	CcSEcCtD
Bretylium—Hypertension—Doxorubicin—uterine cancer	0.00182	0.00294	CcSEcCtD
Bretylium—Hyperhidrosis—Epirubicin—uterine cancer	0.0018	0.00291	CcSEcCtD
Bretylium—Anxiety—Doxorubicin—uterine cancer	0.00179	0.00289	CcSEcCtD
Bretylium—Confusional state—Doxorubicin—uterine cancer	0.00174	0.0028	CcSEcCtD
Bretylium—Shock—Doxorubicin—uterine cancer	0.0017	0.00274	CcSEcCtD
Bretylium—Hyperhidrosis—Doxorubicin—uterine cancer	0.00167	0.00269	CcSEcCtD
Bretylium—Dyspnoea—Epirubicin—uterine cancer	0.00166	0.00268	CcSEcCtD
Bretylium—Dyspnoea—Doxorubicin—uterine cancer	0.00154	0.00248	CcSEcCtD
Bretylium—Feeling abnormal—Epirubicin—uterine cancer	0.00153	0.00248	CcSEcCtD
Bretylium—Gastrointestinal pain—Epirubicin—uterine cancer	0.00152	0.00246	CcSEcCtD
Bretylium—Abdominal pain—Epirubicin—uterine cancer	0.00147	0.00238	CcSEcCtD
Bretylium—Body temperature increased—Epirubicin—uterine cancer	0.00147	0.00238	CcSEcCtD
Bretylium—Feeling abnormal—Doxorubicin—uterine cancer	0.00142	0.00229	CcSEcCtD
Bretylium—Gastrointestinal pain—Doxorubicin—uterine cancer	0.00141	0.00227	CcSEcCtD
Bretylium—Body temperature increased—Doxorubicin—uterine cancer	0.00136	0.0022	CcSEcCtD
Bretylium—Abdominal pain—Doxorubicin—uterine cancer	0.00136	0.0022	CcSEcCtD
Bretylium—Diarrhoea—Epirubicin—uterine cancer	0.00127	0.00206	CcSEcCtD
Bretylium—Dizziness—Epirubicin—uterine cancer	0.00123	0.00199	CcSEcCtD
Bretylium—Vomiting—Epirubicin—uterine cancer	0.00118	0.00191	CcSEcCtD
Bretylium—Diarrhoea—Doxorubicin—uterine cancer	0.00118	0.0019	CcSEcCtD
Bretylium—Dizziness—Doxorubicin—uterine cancer	0.00114	0.00184	CcSEcCtD
Bretylium—Nausea—Epirubicin—uterine cancer	0.00111	0.00179	CcSEcCtD
Bretylium—Vomiting—Doxorubicin—uterine cancer	0.0011	0.00177	CcSEcCtD
Bretylium—Nausea—Doxorubicin—uterine cancer	0.00102	0.00165	CcSEcCtD
